Spain Overtakes Amsterdam As Popularity of Cannabis Clubs Soars


By Steve Elliott
Hemp News

Spain has overtaken the Netherlands as a marijuana smoking nation, and with the soaring popularity of its cannabis clubs, it has been dubbed the new Amsterdam.

Ranking third in the world for marijuana use, behind only Iceland the the United States, according to Recovery Brands, which operates addiction rehab and recovery websites, Spain has 10 percent of its population regularly getting high, reports Emma Anderson at The Local.

Iceland is at the top weed smoking nation in the world, with between 160 and 190 people smoking pot per 1,000 adults, according to Recovery, while Americans come in second with between 130 and 160 users per 1,000 adults.

The fact that cannabis is cheaper in Spain than in many other parts of Europe adds to its popularity as a marijuana destination. The new legal members-only cannabis clubs take advantage of a provision in Spain's pot laws that forbid trafficking it or smoking in public, but allow cannabis to be grown and consumed for private use.

Global: Voices Against Brain Cancer Partners With Spanish Cannabinoid Research Group


The Cannabinoid Research Group of Complutense University in Madrid, Spain and Voices Against Brain Cancer, a U.S. foundation headquartered in New York, on Monday announced that a collaborative medical marijuana research alliance has been signed by both organizations.

The consideration of the benefits of marijuana and the compounds contained within the plant known as "cannabinoids" for medicinal purposes is currently a prominent subject matter in North America. In an effort to fast-track the propagation of accurate scientific based information on therapeutic opportunities incorporating cannabinoids, these two groups have formed an exclusive partnership in the United States.

"We have chosen Voices Against Brain Cancer to act as our voice in North America where they will support and herald our efforts," said Manuel Guzmán, chairman of The Cannabinoid Research Group. When asked about the research findings to date, Guzman noted that "published research clearly shows the anticancer action of cannabinoids impacting glioblastoma multiforma (GBM), and how chemotherapy results of tumor reduction are improved upon by adding cannabinoids as part of the treatment regimen."

"We have an obligation to remain open minded about where the cure for brain cancer will come from," said Michael Klipper, chairman of Voices Against Brain Cancer. "Manuel Guzmán and his research team are world class leaders in the clinical research of cannabinoids and cancer."

Syndicate content